In vitro susceptibility of four serotypes of enterohaemorrhagic Escherichia coli to antimicrobial agents

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 5, 2002, Pages 671-673

  Oie, Shigeharu ^a   Kawakami, Masatada ^a   Kamiya, Akira ^a   Tomita, Masaaki ^b  

^a YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^b Yamaguchi Prefectural Research Institute of Public Health   (Japan)

Author keywords

Cefoperazone; Ciprofloxacin; Enterohaemorrhagic Escherichia coli; Fosfomycin; Norfloxacin; Susceptibility

Indexed keywords

AGAR; ANTIINFECTIVE AGENT; BACTERIAL DNA; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; FOSFOMYCIN; GLUCOSE 6 PHOSPHATE; KANAMYCIN; NORFLOXACIN;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG SCREENING; DRUG SENSITIVITY; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEROTYPE; DRUG EFFECT; ENTEROBACTER INFECTION; ESCHERICHIA COLI O157; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; MICROBIAL SENSITIVITY TESTS;

EID: 0036581583     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.671     Document Type: Article

References (19)

1. Riley L. W., Remis R. S., Helgerson S. D., McGee H. B., Wells J. G., Davis B. R., Hebert R. J., Olcott E. S., Johnson L. M., Hargrett N. T., Blake P. A., Cohen M. L., N. Engl. J. Med., 308, 681-685 (1983).
2. Boyce T. G., Swerdlow D. L., Griffin P. M., N. Engl. J. Med., 333, 364-368 (1995).
3. Fukushima H., Hashizume T., Morita Y., Tanaka J., Azuma K., Mizumoto Y., Kaneno M., Matsuura M., Konma K., Kitani T., Pediatr. Int., 41, 213-217 (1999).
4. Takahashi K., Narita K., Kato Y., Sugiyama T., Koide N., Yoshida T., Yokochi T., Antimicrob. Agents Chemother., 41, 2295-2296 (1997).
5. Ito T., Akino E., Hiramatsu K., Kansenshogaku Zasshi, 71, 130-135 (1997).
6. Robson W. L. M., Scott R. B., Fick G. H., J. Pediatr., 116, 589-592 (1990).
7. Proulx F., Turgeon J. P., Delage G., Lafleur L., Chicoine L., J. Pediatr., 121, 299-303 (1992).
8. Higami S., Nishimoto K., Kawamura T., Tsuruhara T., Isshiki G., Ookita A., Kansenshogaku Zasshi, 72, 266-272 (1997).
9. Shiomi M., Togawa M., Fujita K., Murata R., Pediatr. Int., 41, 228-232 (1999).
10. Yoshimura K., Fujii J., Taniguchi H., Yoshida S. Immun. Med. Microbiol., 6, 101-108 (1999).
11. Stock I., Wiedemann B., Diagn. Microbiol. Infect. Dis., 33, 187-199 (1999).
12. Tsuboi I., Ida H., Yoshikawa E., Hiyoshi S., Yamaji E., Nakayama I., Nonomiya T., Shigenobu F., Shimizu M., Hara K., Sawa T., Mizuoka K., Antimicrob. Agents Chemother., 42, 431-432 (1998).
13. Oie S., Kamiya A., Tomita M., Matsusaki S., Katayama A., Iwasaki A., Biol. Pharm. Bull., 20, 584-585 (1997).
14. Barry A. L., Fuchs P. C., Antimicrob. Agents Chemother., 35, 1235-1238 (1991).
15. Murray B. E., Shingh K. V., Markowitz S. M., Lopardo H. A., Patterson J. E., Zervos M. J., Rubeglio E., Eliopoulos G. M., Rice L. B., Goldstein F. W., Jenkins S. G., Caputo G. M., Nasnas R., Moore L. S., Wong E. S., Weinstock G., J. Infect. Dis., 163, 780-785 (1991).
16. Yukioka H., Kurita S., Eur. J. Emerg. Med., 4, 165 (1997).
17. Swerdlow D. L., Woodruff B. A., Brady R. C., Griffin P. M., Tippen S., Donnell H. D., Ann. Intern. Med., 117, 812-819 (1992).
18. Meng J., Zhao S., Doyle M. P., Joseph S. W., Food Protect., 61, 1511-1514 (1998).
19. Mbre J. J., Bennett D. R., Cranston J. W., Dickinson B. D., Glade M. J., McCann M. A., "Drug Evalutions Annual 1993," American Medical Association, Chicago, 1993, pp. 1362-1365.